Jul 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2024 Jun 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.30 1.19 5.40
(+8.9 pct) (-4.2 pct) (+6.8 pct)
Operating 266 mln 209 mln 800 mln
(+27.2 pct) (-28.5 pct) (-7.5 pct)
Recurring 266 mln 210 mln 800 mln
(+26.3 pct) (-29.5 pct) (-13.8 pct)
Net 187 mln 143 mln 550 mln
(+30.5 pct) (-28.6 pct) (-13.8 pct)
EPS 44.54 yen 34.48 yen 131.26 yen
Ann Div 32.00 yen 32.00 yen
-Q2 div NIL NIL
-Q4 div 32.00 yen 32.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T